Clinical Trial Record

Return to Clinical Trials

Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer


2023-01-17


2026-03-31


2027-03-31


100

Study Overview

Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer

This clinical trial compares the effect of malnutrition screening and dietary intervention to standard nutrition care on patients with pancreatic cancer that cannot be removed by surgery (unresectable). Fewer than 20% of patients diagnosed with unresectable pancreatic cancer do not survive one year after diagnosis so treatment often focuses on improving quality of life. Many patients experience increasing pain, nausea, vomiting, loss of appetite, weight loss and weakness. Behavioral interventions use techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. Screening for inadequate nutrition (malnutrition) and providing weekly nutritional support may be effective methods to improve nutritional status and improve overall quality of life for patients with unresectable pancreatic cancer.

PRIMARY OBJECTIVES: I. To compare the quality of life of subjects after 12 weeks between the intervention group with nutrition optimization with dietary prescription and nutrition support in comparison to standard care. II. To compare the frequency of hospitalization and length of stay (LOS) after 12 weeks between the intervention group with nutrition optimization with dietary prescription and nutrition support in comparison to standard care. III. To compare the subject's functional status, body weight and dietary intake after 12 weeks between the intervention group with nutrition optimization with dietary prescription and nutrition support in comparison to standard care. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive standard nutrition care and record dietary intake and physical activity using Myfitness Pal smartphone application on study. ARM II: Patients undergo malnutrition screening with a registered dietician at baseline and participate in 12 weekly nutrition support sessions and those at moderate to high risk for malnutrition receive a personalized diet prescription on study. Patients also record dietary intake and physical activity using Myfitness Pal smartphone application on study.

  • Stage III Pancreatic Cancer
  • Pancreatic Adenocarcinoma Non-resectable
  • OTHER: Best Practice
  • OTHER: Dietary Intervention
  • OTHER: Medical Chart Review
  • OTHER: Medical Device Usage and Evaluation
  • OTHER: Nutritional Assessment
  • OTHER: Questionnaire Administration
  • 22-000208
  • NCI-2023-01097 (REGISTRY Identifier) (REGISTRY: CTRP (Clinical Trial Reporting Program))

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2023-10-13  

N/A  

2025-05-09  

2023-10-13  

N/A  

2025-05-13  

2023-10-19  

N/A  

2025-05  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Supportive Care


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
ACTIVE_COMPARATOR: ARM I (Standard of care)

Patients receive standard nutrition care and record dietary intake and physical activity using Myfitness Pal smartphone application on study.

OTHER: Best Practice

  • Receive standard nutrition care

OTHER: Medical Chart Review

  • Ancillary studies

OTHER: Medical Device Usage and Evaluation

  • Record dietary and physical activity using MyFitnessPal smartphone app

OTHER: Questionnaire Administration

  • Ancillary studies
EXPERIMENTAL: ARM II (Dietary intervention)

Patients undergo malnutrition screening with a registered dietician at baseline and participate in 12 weekly nutrition support sessions and those at moderate to high risk for malnutrition receive a personalized diet prescription on study. Patients also re

OTHER: Dietary Intervention

  • Participate in weekly support sessions with diet prescription

OTHER: Medical Chart Review

  • Ancillary studies

OTHER: Medical Device Usage and Evaluation

  • Record dietary and physical activity using MyFitnessPal smartphone app

OTHER: Nutritional Assessment

  • Undergo malnutrition screening

OTHER: Questionnaire Administration

  • Ancillary studies
Primary Outcome MeasuresMeasure DescriptionTime Frame
Quality of life measured comparing changes in outcomes between study armsMeasured using short form 36. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate powerAfter 12 weeks
Frequency of hospitalizationsHospitalization defined as any stay in the hospital > 24 hours. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate powerAfter 12 weeks
Length of hospital stayLength of stay determined by the number of days of hospitalization including the date of admission and not including the day of discharge from the hospital. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate powerAfter 12 weeks
Functional status using Karnofsky performance scoreThe Karnofsky Performance Status (KPS) is a standardized measure used to assess a patient's ability to perform everyday tasks. It ranges from 0 to 100, with higher scores indicating better function.After 12 weeks
Percent change in body weightCollected from patient medical record. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate powerBaseline to after 12 weeks
Average daily stepsDaily steps recorded using MyfitnessPal. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate powerAfter 12 weeks
Calorie intake from Myfitness PalFood intake collected every 4 weeks and uploaded into patients medical record via patient portal. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate powerAfter 12 weeks
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Unresectable pancreatic adenocarcinoma, receiving either 1) no chemotherapy, 2) 1st cycle of chemotherapy, or 3) greater than 1 cycle of chemotherapy if the patient's prognosis is greater than 6 months as determined by oncology collaborators
  • Life expectancy of greater than 3 months and a Karnofsky performance score of 60 or more
  • Adults >= 18 years old male or female

  • Exclusion Criteria:

  • Ascites requiring paracentesis for symptom improvement
  • Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) values greater than 5 times the upper limit of normal
  • Creatinine value greater than 2.0 for men and 1.5 for women
  • Uncontrolled pain
  • Uncontrolled nausea and vomiting

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • Silicon Valley Community Foundation

  • PRINCIPAL_INVESTIGATOR: ZhaoPing Li, UCLA / Jonsson Comprehensive Cancer Center

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available